{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:11:27Z","timestamp":1773904287295,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ctim.2020.102482","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T11:41:20Z","timestamp":1591702880000},"page":"102482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease"],"prefix":"10.1016","volume":"52","author":[{"given":"Ahmed A.","family":"Daak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"Lopez-Toledano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Heeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0005","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/asheducation-2017.1.435","article-title":"Chronic organ failure in adult sickle cell disease","volume":"2017","author":"Vichinsky","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0010","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.trsl.2015.07.001","article-title":"Inflammatory targets of therapy in sickle cell disease","volume":"167","author":"Owusu-Ansah","year":"2016","journal-title":"Transl Res"},{"issue":"20","key":"10.1016\/j.ctim.2020.102482_bib0015","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1182\/bloodadvances.2019000193","article-title":"Role of the coagulation system in the pathogenesis of sickle cell disease","volume":"3","author":"Nasimuzzaman","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bcmd.2015.03.014","article-title":"Omega 3 (n-3) fatty acids down-regulate nuclear factor-kappa B (NF-kappaB) gene and blood cell adhesion molecule expression in patients with homozygous sickle cell disease","volume":"55","author":"Daak","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.ctim.2020.102482_bib0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.nutr.25.051804.101917","article-title":"Polyunsaturated fatty acid regulation of genes of lipid metabolism","volume":"25","author":"Sampath","year":"2005","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/070674370304800308","article-title":"Essential fatty acids and the brain","volume":"48","author":"Haag","year":"2003","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.plefa.2012.08.005","article-title":"A quantum theory for the irreplaceable role of docosahexaenoic acid in neural cell signalling throughout evolution","volume":"88","author":"Crawford","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.ctim.2020.102482_bib0040","first-page":"1","article-title":"The differential effects of EPA and DHA on cardiovascular risk factors","author":"Cottin","year":"2011","journal-title":"Proc Nutr Soc"},{"issue":"3-5","key":"10.1016\/j.ctim.2020.102482_bib0045","first-page":"227","article-title":"Lipid metabolism, atherogenesis, and haemostasis in Eskimos: The role of the prostaglandin-3 family","volume":"8","author":"Dyerberg","year":"1979","journal-title":"Haemostasis"},{"issue":"22","key":"10.1016\/j.ctim.2020.102482_bib0050","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1016\/j.jacc.2019.02.032","article-title":"Effects of icosapent ethyl on total ischemic events: From REDUCE-IT","volume":"73","author":"Bhatt","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0055","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.cardiores.2006.08.019","article-title":"Cardiovascular benefits of omega-3 fatty acids","volume":"73","author":"von Schacky","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ctim.2020.102482_bib0060","doi-asserted-by":"crossref","DOI":"10.1002\/clc.23220","article-title":"Rounding the corner on residual risk: Implications of REDUCE-IT for omega-3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular disease","author":"Baum","year":"2019","journal-title":"Clin Cardiol"},{"issue":"20","key":"10.1016\/j.ctim.2020.102482_bib0065","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1001\/jama.288.20.2569","article-title":"Optimal diets for prevention of coronary heart disease","volume":"288","author":"Hu","year":"2002","journal-title":"Jama"},{"issue":"7","key":"10.1016\/j.ctim.2020.102482_bib0070","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1161\/01.STR.0000130856.31468.47","article-title":"Fish consumption and incidence of stroke: A meta-analysis of cohort studies","volume":"35","author":"He","year":"2004","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.ctim.2020.102482_bib0075","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mnfr.200700289","article-title":"Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases","volume":"52","author":"Calder","year":"2008","journal-title":"Mol Nutr Food Res"},{"issue":"20","key":"10.1016\/j.ctim.2020.102482_bib0080","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: Effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.ctim.2020.102482_bib0085","first-page":"S200","article-title":"Endogenous pro-resolving and anti-inflammatory lipid mediators: A new pharmacologic genus","volume":"153","author":"Serhan","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11745-003-1068-y","article-title":"N-3 polyunsaturated fatty acids and inflammation: From molecular biology to the clinic","volume":"38","author":"Calder","year":"2003","journal-title":"Lipids"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0095","first-page":"174","article-title":"[Fish oil supplementation in rheumatoid arthritis]","volume":"60","author":"Sales","year":"2008","journal-title":"Reumatismo"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0100","first-page":"115","article-title":"Polyunsaturated fatty acids and rheumatoid arthritis","volume":"4","author":"Calder","year":"2001","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"Suppl 1","key":"10.1016\/j.ctim.2020.102482_bib0105","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1079\/BJN2001459","article-title":"n-3 fatty acids in psoriasis","volume":"87","author":"Mayser","year":"2002","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0110","first-page":"284","article-title":"Is there a role for topically delivered eicosapentaenoic acid in the treatment of psoriasis?","volume":"17","author":"Zulfakar","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102482_bib0115","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.hoc.2005.08.004","article-title":"New therapies for sickle cell disease","volume":"19","author":"Okpala","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"10.1016\/j.ctim.2020.102482_bib0120","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s00277-005-1023-7","article-title":"Blood mononuclear cells and platelets have abnormal fatty acid composition in homozygous sickle cell disease","volume":"84","author":"Ren","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ctim.2020.102482_bib0125","article-title":"LC-MS\/MS analysis of plasma polyunsaturated fatty acids in patients with homozygous sickle cell disease","author":"Aslan","year":"2014","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.ctim.2020.102482_bib0130","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/718014","article-title":"Hydroxyurea therapy mobilises arachidonic Acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell disease","volume":"2011","author":"Daak","year":"2011","journal-title":"J Lipids"},{"key":"10.1016\/j.ctim.2020.102482_bib0135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.plefa.2019.05.004","article-title":"Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia","volume":"146","author":"Setty","year":"2019","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"12","key":"10.1016\/j.ctim.2020.102482_bib0140","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1016\/S0022-2275(20)30036-5","article-title":"Abnormal phospholipid molecular species of erythrocytes in sickle cell anemia","volume":"38","author":"Connor","year":"1997","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0145","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/jn\/94.2.138","article-title":"Requirements of the female rat for linoleic and linolenic acids","volume":"94","author":"Pudelkewicz","year":"1968","journal-title":"J Nutr"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0163-7827(91)90006-Q","article-title":"Essential fatty acids in growth and development","volume":"30","author":"Innis","year":"1991","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11745-005-1355-7","article-title":"Highly unsaturated fatty acid synthesis in vertebrates: New insights with the cloning and characterization of a delta6 desaturase of Atlantic salmon","volume":"40","author":"Zheng","year":"2005","journal-title":"Lipids"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0160","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1194\/jlr.M400335-JLR200","article-title":"Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases","volume":"46","author":"Wang","year":"2005","journal-title":"J Lipid Res"},{"issue":"6 Suppl","key":"10.1016\/j.ctim.2020.102482_bib0165","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ctim.2020.102482_bib0170","unstructured":"International Society for the Study of Fatty Acids and Lipids (ISSFAL). Recommendations for intake of polyunsaturated fatty acids in healthy adults, 2004. https:\/\/www.issfal.org\/assets\/issfal%2003%20pufaintakereccomdfinalreport.pdf (accessed June 1, 2020)."},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0175","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0180","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1073\/pnas.85.1.237","article-title":"Accelerated autoxidation and heme loss due to instability of sickle hemoglobin","volume":"85","author":"Hebbel","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ctim.2020.102482_bib0185","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1182\/blood.V76.5.1008.1008","article-title":"Impaired erythrocyte methemoglobin reduction in sickle cell disease: Dependence of methemoglobin reduction on reduced nicotinamide adenine dinucleotide content","volume":"76","author":"Zerez","year":"1990","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0190","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood.V83.1.242.242","article-title":"Denaturing interaction between sickle hemoglobin and phosphatidylserine liposomes","volume":"83","author":"Marva","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ctim.2020.102482_bib0195","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1172\/JCI116121","article-title":"Detection, characterization, and bioavailability of membrane-associated iron in the intact sickle red cell","volume":"90","author":"Sugihara","year":"1992","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0200","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1182\/blood.V71.4.876.876","article-title":"Excess heme in sickle erythrocyte inside-out membranes: Possible role in thiol oxidation","volume":"71","author":"Kuross","year":"1988","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0205","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1182\/blood.V72.4.1278.1278","article-title":"Nonheme iron in sickle erythrocyte membranes: Association with phospholipids and potential role in lipid peroxidation","volume":"72","author":"Kuross","year":"1988","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.ctim.2020.102482_bib0210","doi-asserted-by":"crossref","first-page":"6960","DOI":"10.1016\/S0021-9258(19)44679-6","article-title":"The generation of superoxide radical during the autoxidation of hemoglobin","volume":"247","author":"Misra","year":"1972","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.ctim.2020.102482_bib0215","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1182\/blood.V78.10.2753.2753","article-title":"Hydroxyl radical formation by sickle erythrocyte membranes: Role of pathologic iron deposits and cytoplasmic reducing agents","volume":"78","author":"Repka","year":"1991","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ctim.2020.102482_bib0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.phrs.2008.05.002","article-title":"Polyunsaturated fatty acids as antioxidants","volume":"57","author":"Richard","year":"2008","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0225","doi-asserted-by":"crossref","first-page":"592S","DOI":"10.3945\/jn.111.155259","article-title":"Mechanisms of action of (n-3) fatty acids","volume":"142","author":"Calder","year":"2012","journal-title":"J Nutr"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0230","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0005-2736(93)90216-M","article-title":"Effects of dietary fatty-acid supplementation on fatty-acid composition and deformability of young and old erythrocytes","volume":"1149","author":"Mills","year":"1993","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1388-1981(00)00082-2","article-title":"Arachidonic acid-containing phosphatidylcholine inhibits lymphocyte proliferation and decreases interleukin-2 and interferon-gamma production from concanavalin A-stimulated rat lymphocytes","volume":"1487","author":"Nishiyama","year":"2000","journal-title":"Biochemica et Biophysica Acta"},{"issue":"22","key":"10.1016\/j.ctim.2020.102482_bib0240","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0245","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V58.2.398.398","article-title":"Sickled erythrocytes accelerate clotting in vitro: An effect of abnormal membrane lipid asymmetry","volume":"58","author":"Chiu","year":"1981","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.ctim.2020.102482_bib0250","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity","volume":"302","author":"Hebbel","year":"1980","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0268-960X(96)90018-1","article-title":"The pathophysiology of vascular obstruction in the sickle syndromes","volume":"10","author":"Kaul","year":"1996","journal-title":"Blood Rev"},{"key":"10.1016\/j.ctim.2020.102482_bib0260","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1182\/asheducation.V2000.1.2.20000002","article-title":"New views of sickle cell disease pathophysiology and treatment","author":"Rosse","year":"2000","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.moh.0000190108.62414.06","article-title":"Leukocyte adhesion and the pathophysiology of sickle cell disease","volume":"13","author":"Okpala","year":"2006","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0270","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00062752-200203000-00003","article-title":"Sickle cell vaso-occlusion: Multistep and multicellular paradigm","volume":"9","author":"Frenette","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0275","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1172\/JCI30920","article-title":"Sickle cell disease: Old discoveries, new concepts, and future promise","volume":"117","author":"Frenette","year":"2007","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00041433-199602000-00003","article-title":"Dietary polyunsaturates and peroxidation of low density lipoprotein","volume":"7","author":"Nenseter","year":"1996","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0285","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.CIR.91.4.1123","article-title":"Fish oil treatment decreases superoxide anions in the myocardium and coronary arteries of atherosclerotic monkeys","volume":"91","author":"Supari","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ctim.2020.102482_bib0290","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/0002-8703(93)90524-D","article-title":"Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts","volume":"126","author":"Yang","year":"1993","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0295","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.neuint.2006.11.005","article-title":"The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus","volume":"50","author":"Bas","year":"2007","journal-title":"Neurochem Int"},{"issue":"9","key":"10.1016\/j.ctim.2020.102482_bib0300","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0006-2952(99)00012-X","article-title":"Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes","volume":"57","author":"Bechoua","year":"1999","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0305","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.plefa.2006.05.014","article-title":"Versatile roles of docosahexaenoic acid in the prenatal brain: From pro- and anti-oxidant features to regulation of gene expression","volume":"75","author":"Yavin","year":"2006","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"10.1016\/j.ctim.2020.102482_bib0310","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.plefa.2013.09.006","article-title":"Docosahexaenoic and eicosapentaenoic acid supplementation does not exacerbate oxidative stress or intravascular haemolysis in homozygous sickle cell patients","volume":"89","author":"Daak","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0315","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.20196","article-title":"Cytokine profile of sickle cell disease in Oman","volume":"77","author":"Pathare","year":"2004","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0320","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1189\/jlb.0708445","article-title":"Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy","volume":"85","author":"Lanaro","year":"2009","journal-title":"J Leukoc Biol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102482_bib0325","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2141.2009.08013.x","article-title":"Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises","volume":"148","author":"Krishnan","year":"2010","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.ctim.2020.102482_bib0330","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1182\/blood.V92.7.2551","article-title":"Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis","volume":"92","author":"Graido-Gonzalez","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0335","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2003-10-3719","article-title":"Endothelial cell expression of tissue factor in sickle mice is augmented by hypoxia\/reoxygenation and inhibited by lovastatin","volume":"104","author":"Solovey","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0340","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3324\/haematol.11763","article-title":"Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension","volume":"93","author":"Ataga","year":"2008","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.ctim.2020.102482_bib0345","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0350","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI10726","article-title":"Sickle cell anemia as an inflammatory disease","volume":"106","author":"Platt","year":"2000","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0355","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0268-960X(03)00037-7","article-title":"The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder","volume":"18","author":"Okpala","year":"2004","journal-title":"Blood Rev"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0360","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3324\/haematol.12119","article-title":"Increased adhesive properties of neutrophils in sickle cell disease may be reversed by pharmacological nitric oxide donation","volume":"93","author":"Canalli","year":"2008","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0365","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000083451","article-title":"Effect of cytokines and chemokines on sickle neutrophil adhesion to fibronectin","volume":"113","author":"Assis","year":"2005","journal-title":"Acta Haematol"},{"issue":"5","key":"10.1016\/j.ctim.2020.102482_bib0370","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm","volume":"99","author":"Turhan","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0375","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1871529X10909040271","article-title":"A systems biology consideration of the vasculopathy of sickle cell anemia: The need for multi-modality chemo-prophylaxsis","volume":"9","author":"Hebbel","year":"2009","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"22","key":"10.1016\/j.ctim.2020.102482_bib0380","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1056\/NEJM199711273372203","article-title":"Circulating activated endothelial cells in sickle cell anemia","volume":"337","author":"Solovey","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0385","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI9225","article-title":"Hypoxia\/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice","volume":"106","author":"Kaul","year":"2000","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6","article-title":"Pathophysiology of ischaemia-reperfusion injury","volume":"190","author":"Carden","year":"2000","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0395","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1182\/blood.V96.1.314","article-title":"Reperfusion injury pathophysiology in sickle transgenic mice","volume":"96","author":"Osarogiagbon","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0400","doi-asserted-by":"crossref","first-page":"H293","DOI":"10.1152\/ajpheart.01150.2003","article-title":"Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice","volume":"287","author":"Kaul","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"10.1016\/j.ctim.2020.102482_bib0405","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V97.7.1937","article-title":"Modulation of endothelial cell activation in sickle cell disease: A pilot study","volume":"97","author":"Solovey","year":"2001","journal-title":"Blood"},{"issue":"1-2","key":"10.1016\/j.ctim.2020.102482_bib0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0006-8993(02)02649-5","article-title":"Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in mice","volume":"942","author":"Laufs","year":"2002","journal-title":"Brain Res"},{"issue":"2","key":"10.1016\/j.ctim.2020.102482_bib0415","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1182\/blood-2007-04-084061","article-title":"Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion","volume":"111","author":"Chang","year":"2008","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ctim.2020.102482_bib0420","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1182\/blood-2003-07-2209","article-title":"Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes","volume":"103","author":"Turhan","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.ctim.2020.102482_bib0425","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood-2013-08-523936","article-title":"Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease","volume":"123","author":"Sparkenbaugh","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ctim.2020.102482_bib0430","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.trsl.2009.10.004","article-title":"Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: Implications for the coagulopathy of sickle cell disease","volume":"155","author":"Kollander","year":"2010","journal-title":"Transl Res"},{"key":"10.1016\/j.ctim.2020.102482_bib0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.biochi.2009.01.008","article-title":"Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale","author":"Calder","year":"2009","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0440","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1056-8727(02)00172-1","article-title":"Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus","volume":"17","author":"Nomura","year":"2003","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1172\/JCI200113416","article-title":"Mixed messages: Modulation of inflammation and immune responses by prostaglandins and thromboxanes","volume":"108","author":"Tilley","year":"2001","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0450","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1079\/PNS2002166","article-title":"Dietary modification of inflammation with lipids","volume":"61","author":"Calder","year":"2002","journal-title":"Proc Nutr Soc"},{"issue":"6","key":"10.1016\/j.ctim.2020.102482_bib0455","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1568026611109060629","article-title":"Novel anti-inflammatory--pro-resolving mediators and their receptors","volume":"11","author":"Serhan","year":"2011","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0460","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ajcn\/63.1.116","article-title":"The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil","volume":"63","author":"Caughey","year":"1996","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.ctim.2020.102482_bib0465","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.4049\/jimmunol.171.9.4837","article-title":"Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans","volume":"171","author":"Mayer","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.ctim.2020.102482_bib0470","article-title":"Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease","author":"Wandersee","year":"2014","journal-title":"Blood Cells Mol Dis"},{"issue":"7","key":"10.1016\/j.ctim.2020.102482_bib0475","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.2015.124586","article-title":"Dietary omega-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease","volume":"100","author":"Kalish","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.ctim.2020.102482_bib0480","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood-2018-07-865378","article-title":"Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1","volume":"133","author":"Matte","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ctim.2020.102482_bib0485","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.plefa.2005.03.005","article-title":"Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids","volume":"72","author":"Ren","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"6","key":"10.1016\/j.ctim.2020.102482_bib0490","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/s-0037-1615948","article-title":"Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids","volume":"85","author":"Tomer","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ctim.2020.102482_bib0495","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12878-017-0089-5","article-title":"Coagulation profile of Sudanese children with homozygous sickle cell disease and the effect of treatment with omega-3 fatty acid on the coagulation parameters","volume":"17","author":"Awoda","year":"2017","journal-title":"BMC Hematol"},{"issue":"6","key":"10.1016\/j.ctim.2020.102482_bib0500","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1067\/mlc.2001.115450","article-title":"Thrombogenesis in sickle cell disease","volume":"137","author":"Tomer","year":"2001","journal-title":"J Lab Clin Med"},{"issue":"7","key":"10.1016\/j.ctim.2020.102482_bib0505","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0463.2011.02751.x","article-title":"Pilot study of omega-3 fatty acid supplements in sickle cell disease","volume":"119","author":"Okpala","year":"2011","journal-title":"Apmis"},{"issue":"1","key":"10.1016\/j.ctim.2020.102482_bib0510","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3945\/ajcn.112.036319","article-title":"Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: Randomized, double-blind, placebo-controlled trial","volume":"97","author":"Daak","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10.1016\/j.ctim.2020.102482_bib0515","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s11745-006-0984-1","article-title":"EPA, but not DHA, decreases mean platelet volume in normal subjects","volume":"37","author":"Park","year":"2002","journal-title":"Lipids"},{"issue":"12","key":"10.1016\/j.ctim.2020.102482_bib0520","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11745-999-0481-6","article-title":"Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells","volume":"34","author":"Hashimoto","year":"1999","journal-title":"Lipids"},{"issue":"15","key":"10.1016\/j.ctim.2020.102482_bib0525","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/bloodadvances.2018021444","article-title":"Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial)","volume":"2","author":"Daak","year":"2018","journal-title":"Blood Adv"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229920302879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229920302879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:15:34Z","timestamp":1760807734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229920302879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":105,"alternative-id":["S0965229920302879"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102482","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2020.102482","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102482"}}